Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
featured
  • 76 views
  • 08 Nov, 2020
  • 1 location
featured
Do you suffer from Hemorrhoids?

Do you suffer from Hemorrhoids?

  • 1312 views
  • 08 Nov, 2020
  • 1 location
Treating Acute Pancreatitis With Dabigatran a Pilot Study

Researchers are studying the safety and efficacy of Dabigatran in the treatment of acute pancreatitis.

amylase
acute pancreatitis
  • 5 views
  • 24 Jan, 2021
  • 1 location
A Study of Darunavir in Combination With Cobicistat or Ritonavir and Dabigatran Etexilate in Healthy Participants

single dose dabigatran etexilate (measured in plasma as free and total dabigatran) when co-administered in healthy participants.

  • 5 views
  • 25 Jan, 2021
  • 1 location
Dabigatran for Mitral Stenosis Atrial Fibrillation

Atrial fibrillation (AF) is the most common sustained cardiac arrythmia encountered in clinical practice and patients suffer from this are at increased risk of ischemic stroke and systemic thromboembolism due to the formation and embolism of left atrial thrombi. Current international guidelines recommend non-vitamin K oral anticoagulants (NOACs) for stroke …

  • 0 views
  • 28 Jan, 2021
  • 1 location
Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI

A real world registry to compare dual therapy with Dabigatran/Ticagrelor to dual therapie with Dabigatran/Clopidogrel in patients with an indication for NOAC undergoing PCI in the setting of ACS

  • 0 views
  • 26 Jan, 2021
  • 1 location
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

comparing efficacy and safety of the four NOACs, edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in non-valvular atrial fibrillation across Danish hospitals and cardiology clinics

edoxaban
dabigatran
anticoagulants
apixaban
noac
  • 35 views
  • 22 Jan, 2021
  • 25 locations
Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3 4)

). In the OPTIMA-4 sub-study, 1472 subjects who prefer dabigatran will be randomly assigned in a 1:1 ratio to a dual antithrombotic therapy of dabigatran 110 mg twice daily with ticagrelor 90 mg

acute coronary syndrome
percutaneous coronary intervention
ticagrelor
thrombosis
aspirin
  • 49 views
  • 25 Jan, 2021
  • 1 location
TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation

This study will compare early with late start of treatment with Non-vitamin K oral anticoagulation (NOAC) in adult patients with acute ischemic stroke and atrial fibrillation; it is a registry-based randomized clinical trial (R-RCT) using The Swedish Stroke Register (Riksstroke). Half of the patients will start NOAC early (within 4 …

atrial fibrillation
anticoagulants
anticoagulant therapy
stroke
noac
  • 52 views
  • 24 Jan, 2021
  • 57 locations
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying …

edoxaban
dabigatran
anticoagulants
ticagrelor
fibrillation
  • 112 views
  • 24 Feb, 2021
  • 76 locations